Seres therapeutics is a clinical stage biotechnology company developing new therapies comprised of rationally selected live bacteria consortia. We have a strong development. Our platform seres’ pioneering science, paired with powerful drug development and manufacturing capabilities, underpins its unique therapeutics platform. Seres is developing live biotherapeutics aimed at modulating immune function and promoting protective responses in vulnerable patients, including those with chronic inflammatory. Additional approximately $75m in cash payments are due to seres in 2025, contingent upon seres’ compliance with transition obligations, with the potential for additional.

-

Vídeo educativo para as crianças aprenderem sobre os habitats terrestres e aquáticos. Um habitat é um lugar que tem os ...